Page 94 - Annual Report
P. 94
JN Tata Endowment Lady Tata Memorial Trust (LTMT)
Mr JN Tata, Founder of the Tata Group, believed Established in 1932 by Sir Dorabji Tata, in memory of
strongly that it was important to support the best his wife, Lady Meherbai, the Trust spends four-fifths
and brightest minds in the nation, enabling them to of its income for research in leukemic diseases and
be of the greatest service to the country. The JN Tata one-fifth of its income for research on alleviation of
Endowment was formalised and established in human suffering from diseases in India and
1892, and for more than 129 years now, has selected internationally. The Trust also supports institutional
candidates of excellent calibre and credentials, scientific research, offers a ‘Young Researcher
enabling them to pursue quality higher education Award’ to budding scientists, provides fellowships
at some of the best institutions in the world. A for students pursuing PhD and supports Teachers’
rigorous selection process ensures that only the Training Programs in a number of colleges.
nation’s most talented and gifted students are
awarded the scholarships. From 1892 till March 2021, Indian Awards for alleviation of human suffering
the Endowment has awarded scholarships to 5,419 In response to the online applications invited from
students going abroad for higher studies across Indian Universities and Institutions during 2020-21,
diverse fields. the Trust received a total of 94 projects. From these,
27 projects were shortlisted and the students called
During 2020-21, 48 scholarships were awarded for a for interviews. 10 students’ projects from different
total sum of `33.6 million. Of this, 21 scholars were Universities/Institutes in India were awarded Junior
women. The scholars opted for a total of 7 countries Research Fellowships for the year 2020-21. The list of
to pursue studies in, including the United Kingdom, projects is as follows:
United States, Canada, Germany, the Netherlands,
Sweden and Switzerland.
Name Institute Name Project Title
Mr. Ankith Sherapur Kuvempu University, Karnataka Repositioning HIF-1alpha inhibitor “BP-1B” for DNA Damage Response (DDR) to
induce BRCA”ness in Ovarian Cancer.
Ms. Arati Saptarshi National Institute of Congenital Dyserythropoietic Anemia: Molecular Diagnosis and Diagnostic
Immunohaematology (NIIH), Mumbai Approach in a Cohort of Indian Patients
Ms. Sarawathi K Aravind Medical Research Foundation, Molecular characterization of ocular lymphoma for improved disease prognosis
Tamil Nadu,
Mr. Sriee Viswarubhiny Aravind Medical Research Foundation, Molecular Characterization of Leber's Congenital Amaurosis in
Tamil Nadu, South Indian Cohort
Ms. Durva Panchal National Institute for Research in Investigation of potential metabolites in follicular fluid for chemotactic activity
Reproductive Health, Mumbai
Ms. Roshni S Sri Ramachandra Institute of Higher Evaluating cell surface protein – LIV-1 as a therapeutic target in Triple Negative
Education and Research, Tamil Nadu Breast Cancer patients
Ms. Itti Munshi National Institute for Research in Investigating the Contribution of DNA Damage, Repair and Demethylation in
Reproductive Health, Mumbai Pathogenesis of Endometriosis.
Mr. Pratik Devadiga National Institute for Research in Microbiome correlates of TB reactivation in PLHIV
Reproductive Health, Mumbai
Mr. Muthuganesh M Centre for Stem Cell Research, Engineering T cells with CD19 Chimeric Antigen Receptor (CAR) to target
CMC Vellore B cell malignancies
Ms. Chennu Manisha JSS College of Pharmacy, Tamil Nadu Development of new chemical entities to activate glial eaat-2 transporter
system: a novel strategy for Alzheimer’s disease
87